Artificial Intelligence News and Research

Latest Artificial Intelligence News and Research

Retrieval-augmented AI improves accuracy in cancer care tools

Artificial intelligence tools like ChatGPT are increasingly being explored in cancer care, but they can sometimes produce outdated or incorrect information. In medicine, where accuracy is critical, that risk is a serious concern.

30 Apr 2026

Strong governance needed before widespread use of medical AI

Flinders University experts are warning that artificial intelligence (AI) must be carefully evaluated and governed before it is adopted widely in healthcare, saying rapid advances do not automatically translate into safe use for patients.

30 Apr 2026

Large language model outperforms human doctors in clinical reasoning tasks

A cutting-edge large language model (LLM) outperformed human doctors in common clinical reasoning tasks including emergency room decisions, identifying likely diagnoses, and choosing next steps in management, according to a new study that used real emergency department data.

30 Apr 2026

T1GRS model enhances prediction of genetic risk for Type 1 diabetes

In people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, responsible for regulating blood sugar and providing cells with glucose to produce energy.

30 Apr 2026

Task switching between organ types increases patient mortality rates

When transplant surgeons switched between different organ types in consecutive surgeries, one-year mortality rates in patients increased by 14.8 percent, according to new Virginia Tech research.

30 Apr 2026

AI and CRISPR technologies drive proactive health monitoring

JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive, tech-integrated health monitoring.

30 Apr 2026

How multi-omics is changing what scientists can see in the human immune system

Human systems immunology is using multi-omics, single-cell tools, spatial technologies, and AI to decode immune responses across real-world human cohorts. The review highlights major opportunities for biomarker discovery and precision medicine, while stressing the need for rigorous study design, validation, and careful interpretation.

29 Apr 2026

New hybrid molecule uses Trojan horse approach to treat obesity

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signalling pathway as a "door opener" and delivers an additional metabolic modulator specifically into the target cells.

29 Apr 2026

Building quality into drug development for safer, faster medicines

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 29 Apr 2026

How media choices shape MMR vaccine hesitancy in the US

The study examines how media sources impact MMR vaccine attitudes, revealing a connection between non-mainstream outlets and increased vaccine hesitancy.

29 Apr 2026

AI eye screening shows promise for detecting six metabolic diseases

Researchers developed Reti-Pioneer, an AI retinal imaging framework that screened for six endocrine and metabolic diseases using color fundus photographs and clinical metadata. The system showed moderate-to-strong performance across cohorts, improved specialist decision-making, and demonstrated promising, though still preliminary, potential for faster, scalable disease screening.

29 Apr 2026

Proteomics-driven multi-omics integration transforms understanding of tumor heterogeneity

A recent review shows that proteomics-driven multi-omics integration reveals tumor heterogeneity and functional regulatory networks beyond genomic information, facilitating the discovery of clinically relevant biomarkers and therapeutic targets.

28 Apr 2026

New AI models quickly find compounds that target Lyme bacteria

Tufts University researchers are using AI and machine learning to more quickly identify potential narrow-spectrum antibiotics to prevent and treat Lyme disease, thanks to a generous gift from an alumnus that sped up their timeline by two to three years.

28 Apr 2026

AI tool estimates biological age from photos to predict cancer outcomes

The Mass General Brigham research team behind FaceAge, an artificial intelligence (AI) tool that can estimate a person's biological age from a single photo, is reporting in a new study that estimating biological age from multiple photos taken over time can provide even more information about how well a person with cancer will do with treatment.

28 Apr 2026

New insights into predicting myeloma drug response

Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma therapy.

28 Apr 2026

UC San Diego Health performs first spine surgery on the West Coast using new robotic system

UC San Diego Health is the first health system on the West Coast to perform spine surgery using a new robotic system with advanced imaging and guidance, a major step forward in surgical care.

27 Apr 2026

AI tools can predict ADHD risk years before a formal diagnosis

Attention-deficit/hyperactivity disorder (ADHD) affects millions of children, yet many go years without a diagnosis, missing the chance for early support that can change long-term outcomes even when early signs are present.

27 Apr 2026

New AI tools enhance diagnosis and management of kidney disease

Kidney diseases develop slowly and may not produce any obvious symptoms for a long time. The body can compensate for them so effectively that the patient remains unaware of the problem for years.

25 Apr 2026

Bacterial vesicles emerge as powerful tools against antibiotic resistance

Antibiotic resistance is making bacterial infections harder to treat, demanding new therapeutic strategies. A new review highlights bacterial extracellular vesicles (BEVs) as promising nanoscale tools that can kill pathogens, block infection, enhance vaccines, and deliver drugs.

25 Apr 2026